Specimen Collection Cards Market Size & Growth Forecast 2027–2036, By Segments (Product Type, End-use, Specimen Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Specimen Collection Cards Market size was estimated at USD 504.35 Million in 2026 and is projected to grow at 5.4% CAGR from 2027 to 2036, surpassing USD 853.37 Million by 2036. The industry revenue for 2027 is calculated at USD 527.05 Million.
Get more details on this report
Request Free Sample ReportSpecimen Collection Cards Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through established diagnostic infrastructure, decentralized testing adoption, mature laboratory networks, and strong demand for convenient specimen collection and transportation solutions.
- Asia Pacific is the fastest-growing region, supported by healthcare investment, expanding laboratory infrastructure, disease screening, and demand for accessible testing beyond centralized facilities.
Segment Momentum
- Cotton and cellulose-based cards captured 57.13% of the market in 2026 due to their excellent absorbency, reliable specimen preservation, compatibility with laboratory workflows, and broad use in diagnostic testing applications.
- Diagnostics centers are expanding rapidly as demand for specialized diagnostic services, molecular testing, and decentralized laboratory networks increases, driving greater use of specimen collection cards in dedicated testing facilities.
Market Expansion Drivers
- Rising molecular diagnostics adoption increasing demand for standardized specimen collection formats
- Growth in infectious disease testing accelerating point-of-care sample collection usage
- Expansion of decentralized lab networks driving at-home and remote sample collection adoption
Leading Market Participants
- Prominent companies in the specimen collection cards market include Ahlstrom-Munksjö (Finland), QIAGEN N.V. (Germany), PerkinElmer Inc. (United States), Danaher Corporation (United States), CENTOGENE N.V. (Germany), Cytiva (United States), ARCHIMED Life Science GmbH (Germany), GenTegra LLC (United States), DBS System SA (Switzerland), Eastern Business Forms, Inc. (United States)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 504.35 Million
- 2027 Estimated Market Size: USD 527.05 Million
- Projected Market Size: USD 853.37 Million by 2036
- Growth Forecast: 5.4% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Cotton & Cellulose-Based (Product Type) | Hospitals & Clinics (End-use) | Blood (Specimen Type) | Newborn Screening (NBS) (Application)
- Emerging Opportunity Segment: Cotton & Cellulose-Based (Product Type) | Diagnostics Centers (End-use) | Saliva (Specimen Type) | Infectious Diseases Testing (Application)
Market Growth Drivers and Industry Trends
Rising molecular diagnostics adoption increasing demand for standardized specimen collection formats
The expanding use of molecular diagnostic technologies across clinical laboratories, public health programs, and research institutions is strengthening the need for reliable sample collection methods. This trend will drive the specimen collection cards market growth by increasing demand for standardized formats that preserve sample integrity during transportation, storage, and laboratory processing. Specimen collection cards simplify handling while supporting consistent sample quality, making them well suited for genetic analysis, biomarker testing, and other molecular applications that require dependable specimen preservation.
Growth in infectious disease testing accelerating point-of-care sample collection usage
Increasing emphasis on rapid detection and timely disease surveillance has expanded the use of decentralized diagnostic testing in hospitals, clinics, and community healthcare settings. The specimen collection cards market is supported by greater adoption of point-of-care sample collection solutions that enable convenient specimen acquisition and efficient transport to diagnostic laboratories when required. Their ease of handling, reduced contamination risk, and compatibility with multiple testing workflows make specimen collection cards valuable tools for infectious disease screening programs operating across diverse healthcare environments.
Expansion of decentralized lab networks driving at-home and remote sample collection adoption
Healthcare delivery is increasingly shifting beyond centralized laboratory settings, creating stronger demand for sample collection solutions that are practical for remote use. This transition will boost the specimen collection cards market demand as at-home testing programs, telehealth services, and distributed laboratory networks require collection formats that simplify logistics while maintaining specimen stability. Collection cards enable patients and healthcare providers to obtain samples outside conventional clinical facilities, supporting broader access to diagnostic services in geographically dispersed populations.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising molecular diagnostics adoption increasing demand for standardized specimen collection formats | 2% | High | North America, Europe | High | Near Term |
| Growth in infectious disease testing accelerating point-of-care sample collection usage | 1.8% | High | Asia Pacific | High | Near Term |
| Expansion of decentralized lab networks driving at-home and remote sample collection adoption | 1.5% | Moderate | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of the specimen collection cards market in 2026, supported by well-established diagnostic infrastructure, widespread adoption of decentralized testing, and strong demand for convenient biological sample collection and transportation solutions. The region’s mature healthcare and laboratory networks facilitate the use of specimen collection cards across clinical diagnostics, research, and screening applications. Increasing emphasis on accessible testing and efficient specimen handling is further supporting demand for collection technologies that simplify sample management.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to be the fastest-growing region, driven by expanding diagnostic capabilities, increasing healthcare investment, and growing demand for accessible testing solutions. The development of laboratory infrastructure and greater emphasis on disease screening are encouraging broader adoption of practical specimen collection methods. In addition, rising healthcare awareness and the need to extend diagnostic services beyond centralized facilities are supporting the use of collection cards in geographically diverse and resource-variable settings.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Diagnostic Workflow IntegrationThe U.S. continues integrating specimen collection cards into newborn screening, infectious disease testing, and decentralized diagnostics. Healthcare organizations prioritize standardized sample handling, reliable transport, and compatibility with high-throughput laboratory workflows to improve testing efficiency.
Germany 🇩🇪
Laboratory Quality StandardsGermany emphasizes specimen collection cards that support traceability, analytical consistency, and compliance with laboratory quality requirements. Healthcare providers in Germany increasingly favor validated collection solutions that streamline sample logistics across hospital and reference laboratory networks.
Japan 🇯🇵
Precision Sample HandlingJapan focuses on specimen collection cards that preserve sample integrity for molecular diagnostics and clinical research applications. Laboratories in Japan prioritize compact, contamination-resistant collection formats that integrate efficiently into automated analytical workflows and long-term storage practices.
South Korea 🇰🇷
Molecular Testing SupportSouth Korea is expanding the use of specimen collection cards alongside growing molecular diagnostics and public health testing initiatives. Diagnostic laboratories in South Korea value collection systems that simplify transportation, maintain specimen quality, and support rapid laboratory processing.
France 🇫🇷
Public Health ScreeningFrance supports specimen collection cards through newborn screening programs and centralized diagnostic services requiring standardized sample collection. Healthcare providers in France emphasize dependable specimen preservation and efficient laboratory coordination to strengthen testing accuracy across clinical settings.
Italy 🇮🇹
Decentralized Collection SolutionsItaly is adopting specimen collection cards that facilitate sample collection in hospitals, regional laboratories, and community healthcare settings. Clinical organizations in Italy prioritize user-friendly collection formats that reduce handling complexity while maintaining sample stability during transport.
Segment Leadership and Growth Trends
Specimen Collection Cards Market Share (%), Product Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Cotton & Cellulose-Based (Largest & Fastest-Growing Segment)
The cotton & cellulose-based product type segment dominated the specimen collection cards market, accounting for 57.13% of the market share in 2026, and is also expected to be the fastest-growing segment over the forecast period. Its strong position is supported by the material's excellent absorbency, reliable specimen preservation capabilities, and compatibility with a wide range of laboratory workflows. Cotton and cellulose-based cards are widely preferred for collecting, transporting, and storing biological samples because they help maintain specimen integrity while simplifying handling and processing. Continued expansion of diagnostic testing, newborn screening programs, and molecular analysis applications is expected to reinforce demand, allowing the segment to sustain both its market leadership and growth trajectory.
End-use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Diagnostics Centers (Fastest-Growing Segment)
Hospitals & clinics accounted for the largest share of 57.88% in 2026, reflecting their central role in routine specimen collection, disease diagnosis, and patient management. These healthcare facilities process a high volume of biological samples across diverse clinical departments, creating sustained demand for dependable specimen collection cards. Their established laboratory infrastructure and increasing focus on accurate, standardized sample collection further strengthen the segment's dominant position.
In the specimen collection cards market, the diagnostics centers segment is anticipated to witness the fastest growth over the forecast period. Growing demand for specialized diagnostic services, expanding availability of molecular and genetic testing, and rising adoption of decentralized laboratory networks are contributing to increased utilization of specimen collection cards in dedicated diagnostic facilities. As healthcare providers increasingly outsource testing to specialized laboratories, diagnostics centers are expected to experience accelerated adoption.
Specimen Type Segment Analysis: Blood (Largest Segment) vs Saliva (Fastest-Growing Segment)
Holding the largest share of 82.61% in 2026, the blood specimen segment remained the leading specimen type due to its extensive use in disease diagnosis, newborn screening, infectious disease detection, and genetic analysis. Blood samples provide comprehensive clinical information and are supported by well-established collection and laboratory processing protocols, making them the preferred specimen type across numerous diagnostic applications. The widespread integration of blood-based testing into routine healthcare continues to support the segment's leadership.
The saliva specimen segment is projected to record the fastest growth over the forecast period. Increasing preference for non-invasive sample collection, improved patient comfort, and expanding applications in genetic testing and infectious disease screening are driving its adoption. The ease of self-collection and simplified transportation requirements also make saliva-based specimen collection increasingly attractive for both clinical and remote testing environments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Cotton & Cellulose-Based, Fiber-based, Others | Cotton & Cellulose-Based | Cotton & Cellulose-Based |
| End-use | Hospitals & Clinics, Diagnostics Centers, Others | Hospitals & Clinics | Diagnostics Centers |
| Specimen Type | Blood, Saliva, Urine, Buccal Cell, Others | Blood | Saliva |
| Application | Newborn Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics & Research, Wellbeing/health Monitoring, Others | Newborn Screening (NBS) | Infectious Diseases Testing |
Competitive Landscape and Market Positioning
Major players in the specimen collection cards market:
- Ahlstrom-Munksjö (Finland)
- QIAGEN N.V. (Germany)
- PerkinElmer, Inc. (United States)
- Danaher Corporation (United States)
- CENTOGENE N.V. (Germany)
- Cytiva (United States)
- ARCHIMED Life Science GmbH (Germany)
- GenTegra LLC (United States)
- DBS System SA (Switzerland)
- Eastern Business Forms, Inc. (United States)
Market participants are increasingly differentiating themselves through innovations that improve sample integrity across collection, storage, and transportation rather than competing solely on manufacturing scale. Growing adoption in clinical diagnostics, forensic analysis, and research applications has intensified demand for collection cards that preserve biological materials under diverse environmental conditions while supporting downstream analytical accuracy. Suppliers are responding by refining substrate materials, contamination control, and compatibility with advanced laboratory workflows, making technical performance a more significant competitive factor than standardized product availability. As laboratories seek greater efficiency, providers capable of integrating collection solutions into streamlined testing processes are strengthening their competitive position.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| PerkinElmer | Jul-20 | The company expanded its diagnostic portfolio by introducing a COVID-19 serology test utilizing dried blood spot specimen collection cards. Compatible with the GSP/DELFIA platform, the system enables the processing of up to 5,000 samples, significantly enhancing its high-throughput processing capabilities and competitive positioning within the infectious disease testing landscape. |
| Danaher Corporation | Mar-20 | Danaher completed the acquisition of General Electric's Life Sciences division's Biopharma business for $21.4 billion. Integrated as an independent operating company named Cytiva within Danaher's Life Sciences segment, this transaction materially expands the company's bioprocessing and workflows portfolio, impacting the broader specimen collection and cellular analysis value chain. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Specimen Collection Cards Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Specimen Collection Cards Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the specimen collection cards market?
How much is the specimen collection cards industry expected to grow by 2035?
How is molecular diagnostics driving demand for specimen collection cards?
Why are decentralized healthcare models increasing adoption of specimen collection cards?
Why do cotton and cellulose-based specimen collection cards lead the market?
Why are diagnostics centers the fastest-growing end-use segment in the specimen collection cards market?
How does North America maintain leadership in specimen collection cards?
Where is specimen collection cards adoption growing fastest?
Which companies are driving growth in the specimen collection cards landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization